Mono Pharmacare Q2 Results
- BSE: -
- NSE: MONOPHARMA
- ISIN: INE0OIP01012
- Sector: -
BSE
This stock is not traded on BSE
NSE
23.25
-0.75 (-3.13%)
-0.75 (-3.13%)Volume3.00 L
Updated: Tue 17 Jun, 2025 | 15:59:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹87.16 Cr.(31.01%)
- Operating Profit₹4.67 Cr.(22.31%)
- Profit After Tax₹2.29 Cr.(21.88%)
- Operating Margin5.36%(32.64%)
Note: Comparison is on YoY basis
Quarterly - Mono Pharmacare Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | - | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 87.16 | - | N/A | 66.53 | 31.01% |
| Selling/ General/ Admin Expenses Total | 1.70 | - | N/A | 1.81 | -6.11% |
| Depreciation/ Amortization | 0.06 | - | N/A | 0.05 | 25.64% |
| Other Operating Expenses Total | 1.37 | - | N/A | 0.55 | 149.94% |
| Total Operating Expense | 82.49 | - | N/A | 62.71 | 31.54% |
| Operating Income | 4.67 | - | N/A | 3.82 | 22.31% |
| Net Income Before Taxes | 3.15 | - | N/A | 2.36 | 33.65% |
| Net Income | 2.29 | - | N/A | 1.88 | 21.88% |
| Diluted Normalized EPS | 1.30 | - | N/A | 1.43 | -9.09% |